Metrics as of 10/16/2026, 08:45 AM (Berlin time), refresh in progress.
Roche Holding Stock
Roche Holding AG
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Country
- Switzerland
- CEO
- Thomas Schinecker
- Employees
- 103,249
- Market cap
- CHF261.7 B
- IPO
- 20/08/2003
Roche Holding AG is a prominent global entity in the healthcare sector, primarily active in the pharmaceutical and diagnostics industries. Founded in 1896, the company is headquartered in Basel, Switzerland, and is listed on the SIX. The pharmaceutical division is dedicated to developing and marketing a diverse range…
Company description based on the data provider's company data, AI-assisted, created on 15/10/2026. Not investment advice.
Roche Holding stock: price history
1D
-0.1%
1W
+6.0%
1M
+4.6%
6M
+18.5%
YTD
+15.5%
1Y
+32.9%
2Y
+40.7%
5Y
+5.3%
10Y
+60.8%
Next earnings date
Next earnings date
No date known
Volatility around earnings
~3% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 14/10/26. Not a buy or sell signal.Beta
What does this mean?
Double bottom
BullishThe price bounced off a similar low twice, with a rally in between. This W-shaped pattern is a classic reversal signal from a downtrend into an uptrend.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Roche Holding stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 16/10/2026.
Business model & megatrends
Robust business model that benefits noticeably from at least one megatrend.
2 more assignments (Enabler/Second row) Pro-only.
Roche Holding AG is a globally operating corporation focused on the pharmaceutical and diagnostics industry. The company develops and markets medications for diverse therapeutic areas such as oncology, immunology, and neurosciences. In the diagnostics segment, the company offers in-vitro tests for examining diseases such as diabetes or Covid-19 as well as corresponding instruments and reagents. Business operations extend across numerous international markets including Europe and North America.
- Revenue model
- Hardware sales
- Recurring revenue
- None
- Pricing power
- Strong
- Moat
- Wide
- Moat type
- Network effects
- Capital intensity
- High
- Customer concentration
- Unknown
Ask the agents about Roche Holding
Analyst assessment of Roche Holding
0
STRONG BUY
3
BUY
5
HOLD
1
SELL
0
STRONG SELL
9
TOTAL · Hold
As of: 11/09/2023
Roche Holding stock metrics
P/E
24.69
P/B
9.39
EV/EBITDA
13.2
RETURN ON EQUITY
21.0%
NET MARGIN
22.6%
DEBT/EQUITY
0.97
DIVIDEND YIELD
2.6%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
86.5%
FLOAT SHARES
596,675,895
AVG. DAILY VOLUME (30D)
953,431
Dividends & Stock splits
Dividends
Stock splits
Comparable stocks
Frequently asked questions about Roche Holding stock
What does Roche Holding do?
Roche Holding AG is a company in the Healthcare sector, Drug Manufacturers - General industry, headquartered in Switzerland.
The CEO is Thomas Schinecker, the company employs around 103,249 people.
The IPO was on 20/08/2003; the stock trades on SIX under the ticker ROP.SW.
What do analysts say about Roche Holding stock?
9 analysts rate the stock, the consensus is Hold (as of 11/09/2023).
This is an external assessment, not a statement by Market Jury.
When does Roche Holding report next?
Around past earnings, price swings were roughly 3% stronger than usual.
Does Roche Holding pay a dividend?
Yes. The last dividend was CHF 9.80 per share, ex-date 12/03/2026, paid on 16/03/2026.
The dividend yield is 2.6% (as of 30/06/2026).
Which stocks are comparable to Roche Holding?
Comparable stocks include Roche Holding, Eli Lilly and Company, Johnson & Johnson, AbbVie, Merck &, Amgen, Gilead Sciences and Pfizer.
How can I get Roche Holding stock analyzed?
Clicking "Analyze stock" lets five strategies assess Roche Holding against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.